Almanack Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Almanack Investment Partners's AMGN Position: Q2 2026 in Review
Almanack Investment Partners opened a new position in Amgen (AMGN) in Q2 2026: 2,375 shares worth $860K. The stake represents 0.11% of the portfolio and ranks #120 among its holdings. This is a return to the name: Almanack Investment Partners previously reported a position in AMGN as recently as Q2 2023.
Almanack Investment Partners first reported a position in AMGN in Q2 2017 and has held it in 20 quarters since. The position peaked at $1.21M in Q2 2022. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Almanack Investment Partners held 2,375 shares of Amgen worth $860K as of Q2 2026.
- Amgen was a new Almanack Investment Partners position in Q2 2026.
- Amgen made up 0.11% of Almanack Investment Partners's portfolio in Q2 2026, its #120 holding.
- Almanack Investment Partners first reported a position in Amgen in Q2 2017 and has held it in 20 quarters since.
- Almanack Investment Partners's Amgen position peaked at $1.21M in Q2 2022.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.